Market research
600781.SHG FUREN Group Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 483M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.61
Community
Investor discussion
1 comment
Sign in to join the 600781.SHG discussion.
5 years, 6 months ago
FUREN Group Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 32.5% above its 200 day moving average.
From a valuation standpoint, the stock is 94.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
FUREN Group Pharmaceutical Co., Ltd's total revenue sank by 34.9% to $693M since the same quarter in the previous year.
Its net income has dropped by 83.7% to $23M since the same quarter in the previous year.
Finally, its free cash flow grew by 104.0% to $710K since the same quarter in the previous year.
Based on the above factors, FUREN Group Pharmaceutical Co., Ltd gets an overall score of 3/5.